Inhibitory Activity of Tryptanthrin on Prostaglandin and Leukotriene Synthesis

 

 Buy Article Permissions and Reprints

Abstract

The indolo[2,1-b]quinazoline alkaloid tryptanthrin has previously been identified as the cyclooxygenase-2 (COX-2) inhibitory principle in the extract ZE550 prepared from the medicinal plant Isatis tinctoria (Brassicaceae). We here investigated the potential inhibitory activity of tryptanthrin and ZE550 on COX-2, COX-1 in cellular and cell-free systems. A certain degree of selectivity towards COX-2 was observed when COX-1-dependent formation of thromboxane B₂ (TxB₂) in HEL cells and COX-2-dependent formation of 6-ketoprostaglandin F_{1 α} (6-keto-PGF_{1 α}) in Mono Mac 6 and RAW 264.7 cells were compared. Preferential inhibition of COX-2 by two orders of magnitude was found in phorbol myristate acetate (PMA) activated bovine aortic coronary endothelial cells (BAECs). Assays with purified COX isoenzymes from sheep confirmed the high selectivity towards COX-2. The leukotriene B₄ (LTB₄) release from calcium ionophore-stimulated human granulocytes (neutrophils) was used as a model to determine 5-lipoxygenase (5-LOX) activity. Tryptanthrin and the extract ZE550 inhibited LTB₄ release in a dose dependent manner and with a potency comparable to that of the clinically used 5-LOX inhibitor zileuton.

References

• 1 Blumenthal M. The complete German Commission E Monographs. Austin; American Botanical Council 1998
  Google Scholar
• 2 Ernst E, Chrubasik S. Phyto-anti-inflammatories. A sytematic review of randomized, placebo controlled, double-blind trials.  Rheum Dis Clin North Amer. 2000;  26 13-27
  PubMedGoogle Scholar
• 3 Hamburger M, Danz H. Medicament for inhibiting NF-κB. WO0061159. 
  Google Scholar
• 4 Danz H, Stoyanova S, Wippich P, Brattström A, Hamburger M. Identification and isolation of the cyclooxygenase-2 inhibitory principle in Isatis tinctoria .  Planta Med. 2001;  67 411-6
  Article in Thieme ConnectPubMedGoogle Scholar
• 5 Thomet O AR, Wiesmann U R, Schapowal A, Bizer C, Simon H U. Role of petasin in the potential anti-inflammatory activity of a plant extract of Petasites hybridus .  Biochem Pharmacol. 2001;  61 1041-7
  CrossrefPubMedGoogle Scholar
• 6 Friedlaender P, Roschdestwensky N. Über ein Oxydationsprodukt des Indigblaus.  Chem Ber. 1915;  48 1841-7
  PubMedGoogle Scholar
• 7 Berg J, Christoph T, Widerna M, Bodenteich A. Isoenzyme specific cyclooxygenase inhibitors: A whole cell assay system using the human erythroleukemic cell line HEL and the human monocytic cell line Mono Mac 6.  J Pharmacol Toxicol Methods. 1997;  37 179-86
  CrossrefPubMedGoogle Scholar
• 8 Dannhardt G, Lehr M. In-vitro evaluation of 5-lipoxygenase and cyclooxygenase inhibitors using bovine neutrophils and platelets and HPLC.  J Pharm Pharmacol. 1992;  44 419-24
  PubMedGoogle Scholar
• 9 Dannhardt G, Ulbrich H. In-vitro test system for the evaluation of cyclooxygenase-1 (COX-1) and cycloxygenase-2 (COX-2) inhibitors based on a single HPLC run with UV detection using bovine aortic coronary endothelial cells (BAECs).  Inflamm Res. 2001;  50 262-9
  CrossrefPubMedGoogle Scholar
• 10 Mitchell J A, Akarasereenont P, Thiemermann C, Roderick J F, Vane J R. Selectivity of non-steroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase.  Proc Natl Acad Sci USA. 1994;  90 11 693-7
  PubMedGoogle Scholar
• 11 Dannhardt G, Kiefer W. Cyclooxygenase inhibitors - current status and future prospects.  Eur J Med Chem. 2001;  36 109-26
  CrossrefPubMedGoogle Scholar
• 12 Katori M, Majima M. Cyclooxygenase-2: its rich diversity of roles and possible application of its selective inhibitors.  Inflammation Res. 2000;  49 367-92
  PubMedGoogle Scholar
• 13 Danz H. Untersuchungen zur antiinflammatorischen Wirkung und Analytik von Tryptanthrin in Isatis tinctoria L. PhD Thesis Jena; 2001
  Google Scholar
• 14 Dannhardt G, Laufer S. Structural approaches to explain the selectivity of COX-2 inhibitors: Is there a common pharmacophore?.  Curr Med Chem. 2000;  7 1101-12
  CrossrefPubMedGoogle Scholar
• 15 Ruengeler P, Lyss G, Castro V, Mora G, Pahl H L, Merfort I. Study of three sesquiterpene lactones from Thitonia diversifolia on their anti-inflammatory activity using transcription factor NF-κB and enzymes fo the arachidonic acid pathway as targets.  Planta Med. 1998;  64 588-93
  PubMedGoogle Scholar
• 16 Yamamoto K, Wang J, Yamamoto S, Tobe H. Suppression of cyclooxygenase-2 gene transcription by humulon of beer hop extract studied with reference to glucocorticoid.  FEBS Lett. 2000;  465 103-6
  CrossrefPubMedGoogle Scholar
• 17 Subbarmaiah K, Chung W C, Michaluart P, Telang N, Tanabe T, Inoue H, Jang M, Pezzuto J P, Dannenberg A J. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells.  J Biol Chem. 1998;  273 21 875-82
  PubMedGoogle Scholar
• 18 Bauer R. Cyclooxygenase and 5-lipoxygenase as targets for medicinal plant research. In: Bohlin L, Bruhn JG, editors Bioassay Methods in Natural Product Research and Drug Development. Dordrecht; Kluwer 1999: P. 119-41
  Google Scholar
• 19 Ishihara T, Kohno K, Ushio S, Iwaki K, Ikeda M, Kurimoto M. Tryptanthrin inhibits nitric oxide and prostaglandin E2 synthesis by murine macrophages.  Eur J Pharmacol. 2000;  407 197-204
  CrossrefPubMedGoogle Scholar
• 20 Moon C, Murakami M, Kudo I, Son K H, Kim H P, Kang S S, Chang H W. A new class of COX-2 inhibitor, rutaecarpine, from Evodia rutaecarpa .  Inflammation Res. 1999;  48 621-5
  PubMedGoogle Scholar
• 21 Laufer S, Augustin J, Dannhardt G, Kiefer W. (6,7-Diaryldihydropyrrolizin-5-yl)acetic acids, a novel class of potent dual inhibitors of both cyclooxygenase and 5-lipoxygenase.  J Med Chem. 1994;  37 1894-7
  CrossrefPubMedGoogle Scholar
• 22 Anonynous . Darbufelon mesilate.  Drugs Fut. 1999;  24 853-7
  CrossrefPubMedGoogle Scholar
• 23 Steinhilber D. 5-Lipoxygenase: a target for anti-inflammatory drugs revisited.  Curr Med Chem. 1999;  6 71-85
  PubMedGoogle Scholar
• 24 Inagaki M, Tsuri T, Jyoyama H, Ono T, Yamada K, Kobayashi M, Hori Y, Arimura A, Yasui K, Ohno K, Kakudo K, Koizumi K, Suzuki R, Kato M, Kawai S, Matsumoto S. Novel antiarthritic agents with 1,2-isothiazolidine-1,1-dioxide (g-sultam) skeleton: cytokine suppressive dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase.  J Med Chem. 2000;  43 2040-8
  CrossrefPubMedGoogle Scholar

Prof. Dr. Matthias Hamburger

Institute of Pharmacy

University of Jena

Semmelweissstrasse 10

07743 Jena

Germany

Email: b7hama@rz.uni-jena.de

Fax: +49 3641 949842